The company will be forming joint-venture opportunities with spine and other orthopedic surgeons in markets around the country. SMDC’s purpose will be achieving cost containment of surgical implants in the operating room for hospitals and other surgical facilities.
SMDC will own a minimum of 60 percent of each operating entity, and participating surgeons will own up to 40 percent. This structure complies with regulatory issues, including federal anti-kickback legislation and state laws.
The goal of the joint ventures will be to reduce the cost of surgical implants, develop quality assurance standards and track patient outcomes for payors while holding down the rising cost of implants.
More Articles on Orthopedic Devices:
Internal Fixation Systems Enters Into Agreement With Intelligent Orthopaedics for Trauma Device
U.S. Orthopedic Biomaterials Market Poised for Growth
TranS1 Q1 Revenue Plummets 26%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.